Stocks to Buy, Sell or Hold : The earning season for the June quarter of the financial year 2025 is going on. The financial results of the companies are giving indications of their financial position and business outlook. At the same time, looking at the earnings of the companies, brokerage houses are also forming their opinion about investing in them or staying away from them. After the recently released results, the brokerage has advised to invest in some such popular shares or sell them. If you are also planning to invest in the market, then you can take a look at the latest list of the brokerage house. According to this list, there are some stocks of the choice of retail investors in the market, which are expected to rise and some to fall in the coming days.
Latest List of Brokerage Houses
You can take a look at the latest list of brokerage houses (Brokerage Houses Favourite Stocks) to know which stocks should be sold or bought in the current mood and environment. Brokerages recommend investing in only those stocks (Brokerage Recommendations) whose fundamentals are strong. Or they recommend selling those stocks whose fundamentals are weak. Brokerage houses form their opinion by looking at factors such as fundamentals of any stock, growth outlook, company’s business model, company’s ability to sustain strongly in future, product innovation or by doing proper research and on the basis of this, they advise to buy or stay away from the stock.
Tech Mahindra
After the quarterly results, Tech Mahindra shares are rising and it is trading at Rs 1544. However, brokerage houses are looking cautious about the stock and have reduced its rating.
Brokerage house Citi has given a Sell rating on Tech Mahindra, although the target price has been increased slightly to Rs 1260. Brokerage house UBS has also given a Sell rating on Tech Mahindra and has given a target price of Rs 1250.
Brokerage house Nuvama has given a Reduce rating on Tech Mahindra and has set a target price of Rs 1200 per share. While brokerage house Nomura has given a Buy rating on Tech Mahindra and has raised the target price to Rs 1600 per share.
Brokerage house Motilal Oswal has given a Neutral rating to Tech Mahindra and has set the target price for the stock at Rs 1470. Brokerage house ICICI Securities has given an ADD rating to Tech Mahindra and has set the target price at Rs 1630 per share.
Ashok Leyland
After the results, Ashok Leyland’s stock strengthened by about 6 percent to reach Rs 249, while on Thursday it closed at Rs 232. After the results, brokerage opinion on the stock is mixed.
Brokerage house UBS has given a Buy rating to Ashok Leyland and has set the target price for the stock at Rs 280. Brokerage house Macquarie has given a Neutral rating to Ashok Leyland and has set the target price for the stock at Rs 220.
Laurus Lab
Brokerage house Goldman Sachs has given a Sell rating on the stock of Laurus Labs and has set the target price for the stock at Rs 350. Brokerage house Jefferies has given an Underperform rating on the stock of Laurus Labs and has set the target price for the stock at Rs 250.
Cyient
Brokerage house Nuvama has given a Hold rating on Cyient’s stock and has set the target price for the stock at Rs 1840. Brokerage house Morgan Stanley has given an Underweight rating on Cyient’s stock and has set the target price for the stock at Rs 1550.
Ramco Cement
Brokerage house CLSA has given an Underperform rating to the stock of Ramco Cement and has set the target price for the stock at Rs 685. Brokerage house Citi has given a Sell rating to the stock of Ramco Cement and has set the target price for the stock at Rs 750 per share.
Nestle India
Brokerage house ICICI Securities has given HOLD rating on Nestle India and has set the target price for the stock at Rs 2500. Brokerage house BofA has given Neutral rating on Nestle India and has set the target price at Rs 2675 per share.
Federal Bank
Brokerage house ICICI Securities has given BUY rating on Federal Bank stock and has set a target price of Rs 235 for the stock.
Axis Bank
Brokerage house ICICI Securities has given BUY rating on Axis Bank stock and has set a target price of Rs 1430 for the stock.
Mankind Pharma
Brokerage house Motilal Oswal has given BUY rating on Mankind Pharma stock and has set the target price of Rs 2650 for the stock.
(Disclaimer: Investing or selling stocks is advised by the brokerage house. These are not the personal views of Financial Express. There are risks in the market, so take expert advice before investing.)
